1
|
Hampton M, McNamara S. The impact of educational rewards on the diagnosis of autism spectrum disorder. Econ Hum Biol 2022; 47:101188. [PMID: 36272247 DOI: 10.1016/j.ehb.2022.101188] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/23/2021] [Revised: 07/19/2022] [Accepted: 09/27/2022] [Indexed: 06/16/2023]
Abstract
Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder that affects social interactions and communication. The prevalence of ASD has risen dramatically in recent years, but the underlying factors leading to this rise are not clear. In this paper, we test whether changes in state-level educational policy that impact school-level resources are associated with the rise in ASD diagnostic prevalence. Early identification of ASD can improve an array of outcomes for children, and school systems play an important role with identification of the condition. It is plausible that children attending schools with better resources from state governments are more likely to receive an ASD diagnosis and presumably appropriate services. We focus on one educational policy in particular, state-level rewards, which consist of a monetary transfer from state governments to school districts. To test the impact of educational rewards on ASD diagnosis, we rely on policy variation across states and time and estimate both two-way fixed effects (TWFE) models alongside recently advanced methods in the difference-in-differences (DiD) literature. Under a baseline TWFE specification we estimate that rewards policies are associated with a 18.46% increase in ASD diagnosis. Further, using DiD methods that account for bias in settings of differential policy timing, we find that the magnitude of the effect increases to 24.8%. We believe these findings to be suggestive evidence that educational rewards policies improved the likelihood of detection and diagnosis of ASD.
Collapse
Affiliation(s)
- Matt Hampton
- Department of Accounting, Finance, and Economics, Austin Peay State University, College of Business, Clarksville, TN 37040, USA.
| | - Scott McNamara
- Department of Kinesiology, University of New Hampshire, College of Health and Human Services, Durham, NH 03824.
| |
Collapse
|
2
|
McNamara S, Vajda J, Cassidy J, Bridges G, Guillette C, Sistek K, Goffin B, Brunson A, Ong T. 97 Improving oral glucose tolerance testing rate through a cross-disciplinary quality improvement collaboration. J Cyst Fibros 2022. [DOI: 10.1016/s1569-1993(22)00788-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
3
|
Cumpanasoiu C, Enrique A, Palacios J, Duffy D, McNamara S, Richards D. Trajectories of symptoms in digital interventions for depression and anxiety using Routine Outcome Monitoring data: A secondary analysis study (Preprint). JMIR Mhealth Uhealth 2022. [PMID: 37436812 PMCID: PMC10372559 DOI: 10.2196/41815] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/05/2022] Open
Abstract
BACKGROUND Research suggests there is heterogeneity in treatment response for internet-delivered cognitive behavioral therapy (iCBT) users, but few studies have investigated the trajectory of individual symptom change across iCBT treatment. Large patient data sets using routine outcome measures allows the investigation of treatment effects over time as well as the relationship between outcomes and platform use. Understanding trajectories of symptom change, as well as associated characteristics, may prove important for tailoring interventions or identifying patients who may not benefit from the intervention. OBJECTIVE We aimed to identify latent trajectories of symptom change during the iCBT treatment course for depression and anxiety and to investigate the patients' characteristics and platform use for each of these classes. METHODS This is a secondary analysis of data from a randomized controlled trial designed to examine the effectiveness of guided iCBT for anxiety and depression in the UK Improving Access to Psychological Therapies (IAPT) program. This study included patients from the intervention group (N=256) and followed a longitudinal retrospective design. As part of the IAPT's routine outcome monitoring system, patients were prompted to complete the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7) after each supporter review during the treatment period. Latent class growth analysis was used to identify the underlying trajectories of symptom change across the treatment period for both depression and anxiety. Differences in patient characteristics were then evaluated between these trajectory classes, and the presence of a time-varying relationship between platform use and trajectory classes was investigated. RESULTS Five-class models were identified as optimal for both PHQ-9 and GAD-7. Around two-thirds (PHQ-9: 155/221, 70.1%; GAD-7: 156/221, 70.6%) of the sample formed various trajectories of improvement classes that differed in baseline score, the pace of symptom change, and final clinical outcome score. The remaining patients were in 2 smaller groups: one that saw minimal to no gains and another with consistently high scores across the treatment journey. Baseline severity, medication status, and program assigned were significantly associated (P<.001) with different trajectories. Although we did not find a time-varying relationship between use and trajectory classes, we found an overall effect of time on platform use, suggesting that all participants used the intervention significantly more in the first 4 weeks (P<.001). CONCLUSIONS Most patients benefit from treatment, and the various patterns of improvement have implications for how the iCBT intervention is delivered. Identifying predictors of nonresponse or early response might inform the level of support and monitoring required for different types of patients. Further work is necessary to explore the differences between these trajectories to understand what works best for whom and to identify early on those patients who are less likely to benefit from treatment.
Collapse
|
4
|
Rosenfeld M, Ong T, Carlin K, McNamara S, Gorry S, Kanter A, Gibson R, Cassidy J, Greene L, Choi M, Reonal R, Culley L, Thompson J. 68: Improving timeliness of CF diagnosis following a positive CF newborn screen in Washington State. J Cyst Fibros 2021. [DOI: 10.1016/s1569-1993(21)01493-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
5
|
Cassidy J, McNamara S, Gorry S, Hughes R, Vajda J, Hill L, Akers M, Greene L, Ong T. 144: Quality improvement process to improve home spirometer use in a pediatric CF care center. J Cyst Fibros 2021. [DOI: 10.1016/s1569-1993(21)01569-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
6
|
Townsley M, Waldron J, Alborn-Yilek S, Schares D, Huckstadt K, McNamara S, Gute D. School Administrators' Experiences in a 6-Month Health and Wellness Community of Practice. J Sch Health 2021; 91:857-866. [PMID: 34396538 DOI: 10.1111/josh.13073] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/28/2019] [Revised: 01/04/2021] [Accepted: 01/27/2021] [Indexed: 06/13/2023]
Abstract
BACKGROUND A statewide 6-month school administrator health and wellness program encouraged participants to use a fitness tracker to self-monitor their physical activity and sleep patterns. The purpose of this study was to examine participants' experience in a school administrator health and wellness program and their perceptions of the impact on health-related behaviors, including activity/movement, nutrition, and sleep. METHODS Each of the 45 participants completed a semi-structured interview at three points in the program. Questions were designed to discern school administrators' perceptions of their ideal health and wellness balance at home and work. RESULTS School administrators reported new insights into their own well-being, benefits of social supports in their personal wellness journey, an expanded understanding of their ideal health and wellness balance at home and work, and a stronger sense of serving as a role model who needs to take care of him/herself. CONCLUSIONS Although the program was helpful in establishing an ideal health and wellness balance at home and work for some school administrators, future programs should better emphasize nutrition and scaffold opportunities to maintain new habits following program completion.
Collapse
Affiliation(s)
- Matt Townsley
- University of Northern Iowa, 601D Schindler Education Center, Cedar Falls, IA, 50614
| | - Jennifer Waldron
- University of Northern Iowa, 110 Lang Hall, Cedar Falls, IA, 50614
| | - Susan Alborn-Yilek
- University of Northern Iowa, 601G Schindler Education Center, Cedar Falls, IA, 50614
| | - Denise Schares
- University of Northern Iowa, 601C Schindler Education Center, Cedar Falls, IA, 50614
| | - Kim Huckstadt
- University of Northern Iowa, 601F Schindler Education Center, Cedar Falls, IA, 50614
| | - Scott McNamara
- University of New Hampshire, New Hampshire Hall, 124 Main Street, Durham, NH, 03824
| | - Deeanne Gute
- University of Northern Iowa, Cedar Falls, IA, 50614
| |
Collapse
|
7
|
Stratman S, Schneider C, McNamara S, Lev-Tov H. 389 Association of multiparity and venous insufficiency in Hispanic women. J Invest Dermatol 2021. [DOI: 10.1016/j.jid.2021.02.411] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
8
|
Moriarty T, Bourbeau K, Fontana F, McNamara S, Pereira da Silva M. The Relationship between Psychological Stress and Healthy Lifestyle Behaviors during COVID-19 among Students in a US Midwest University. Int J Environ Res Public Health 2021; 18:4752. [PMID: 33946873 PMCID: PMC8125243 DOI: 10.3390/ijerph18094752] [Citation(s) in RCA: 21] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 03/25/2021] [Revised: 04/14/2021] [Accepted: 04/23/2021] [Indexed: 01/18/2023]
Abstract
The gripping coronavirus disease (COVID-19) has imposed dramatic changes to many areas of daily living in all sectors of society across the world. We examined the relationship between perceived stress and health behaviors among college students during the COVID-19 pandemic. An online survey with measures of psychological stress, physical activity and exercise, and sleep and social connectedness was distributed in June and July of 2020. The survey was completed by 550 college students (mean age: 21.3 ± 3.8 years, 74.2% female, 94.4% Caucasian). Being female and unemployed and having a lower annual income were significantly associated with higher levels of stress. In addition, regression analysis found that reduced exercise and sleep during the COVID-19 pandemic significantly predicted the levels of stress of participants after controlling for gender, employment status, and annual income. University officials should aim to implement health-promotion strategies directed at preventing reductions in exercise and sleep duration, especially in those at greater risk of increased perceived stress such as females and economically disadvantaged students.
Collapse
Affiliation(s)
- Terence Moriarty
- Department of Kinesiology, University of Northern Iowa, Cedar Falls, IA 50614, USA; (K.B.); (F.F.); (S.M.)
| | - Kelsey Bourbeau
- Department of Kinesiology, University of Northern Iowa, Cedar Falls, IA 50614, USA; (K.B.); (F.F.); (S.M.)
| | - Fabio Fontana
- Department of Kinesiology, University of Northern Iowa, Cedar Falls, IA 50614, USA; (K.B.); (F.F.); (S.M.)
| | - Scott McNamara
- Department of Kinesiology, University of Northern Iowa, Cedar Falls, IA 50614, USA; (K.B.); (F.F.); (S.M.)
| | | |
Collapse
|
9
|
Pope CE, Vo AT, Hayden HS, Weiss EJ, Durfey S, McNamara S, Ratjen A, Grogan B, Carter S, Nay L, Parsek MR, Singh PK, McKone EF, Aitken ML, Rosenfeld MR, Hoffman LR. Changes in fecal microbiota with CFTR modulator therapy: A pilot study. J Cyst Fibros 2021; 20:742-746. [PMID: 33390317 DOI: 10.1016/j.jcf.2020.12.002] [Citation(s) in RCA: 16] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2020] [Revised: 11/18/2020] [Accepted: 12/03/2020] [Indexed: 11/28/2022]
Abstract
Studies have demonstrated that people with CF with pancreatic insufficiency (PI) have fecal dysbioses. Evidence suggests the causes of these dysbioses are multifactorial, and that important drivers include antibiotic exposure, dietary intake, and CF gastrointestinal tract dysfunction, including nutrient malabsorption. In this pilot study, we tested whether initiation of the CFTR modulator treatments ivacaftor (in a cohort of pancreatic sufficient (PS) people with CF and an R117H CFTR variant) or lumacaftor/ivacaftor (in a cohort of PI people with CF and an F508del variant) changed fecal measures of malabsorption or fecal microbiomes. While we identified no statistically significant fecal changes with either treatment, we detected trends in the PI cohort when initiating lumacaftor/ivacaftor towards decreased fecal fat content and towards fecal microbiomes that more closely resembled the fecal microbiota of people without PI. While these findings support a model in which nutrient malabsorption resulting from CF-induced PI drives fecal dysbiosis, they must be validated in future, larger studies of fecal microbiome and malabsorption outcomes with highly effective CFTR modulator therapies.
Collapse
Affiliation(s)
- C E Pope
- University of Washington, Seattle, USA
| | - A T Vo
- University of Washington, Seattle, USA
| | | | - E J Weiss
- University of Washington, Seattle, USA
| | - S Durfey
- University of Washington, Seattle, USA
| | | | - A Ratjen
- University of Washington, Seattle, USA
| | - B Grogan
- St. Vincent's University Hospital, Dublin, Ireland
| | - S Carter
- St. Vincent's University Hospital, Dublin, Ireland
| | - L Nay
- University of Washington, Seattle, USA
| | | | - P K Singh
- University of Washington, Seattle, USA
| | - E F McKone
- St. Vincent's University Hospital, Dublin, Ireland
| | | | | | | |
Collapse
|
10
|
Solomon J, Moss E, Morin J, Langlois Y, Joyal D, Lachapelle K, Ma F, Cecere R, De Varennes B, Bendayan M, Piankova P, Hayman V, Ouimet M, McNamara S, Rudski L, Afilalo J. THE ESSENTIAL FRAILTY TOOLSET IN OLDER ADULTS UNDERGOING ISOLATED CABG. Can J Cardiol 2020. [DOI: 10.1016/j.cjca.2020.07.219] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
11
|
Gérard A, Woolfe A, Mottet G, Reichen M, Castrillon C, Menrath V, Ellouze S, Poitou A, Doineau R, Briseno-Roa L, Canales-Herrerias P, Mary P, Rose G, Ortega C, Delincé M, Essono S, Jia B, Iannascoli B, Richard-Le Goff O, Kumar R, Stewart SN, Pousse Y, Shen B, Grosselin K, Saudemont B, Sautel-Caillé A, Godina A, McNamara S, Eyer K, Millot GA, Baudry J, England P, Nizak C, Jensen A, Griffiths AD, Bruhns P, Brenan C. Author Correction: High-throughput single-cell activity-based screening and sequencing of antibodies using droplet microfluidics. Nat Biotechnol 2020; 38:756. [PMID: 32444853 DOI: 10.1038/s41587-020-0563-7] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Collapse
Affiliation(s)
| | | | - Guillaume Mottet
- Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France
| | | | - Carlos Castrillon
- Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France.,École Doctorale Frontières du Vivant (FdV), Centre de Recherches Interdisciplinaires, Paris, France.,Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France
| | | | | | | | - Raphaël Doineau
- HiFiBiO Therapeutics SAS, Paris, France.,École Doctorale Frontières du Vivant (FdV), Centre de Recherches Interdisciplinaires, Paris, France.,Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.,Institute for Integrative Nanosciences, Leibniz IFW Dresden e.V., Dresden, Germany
| | - Luis Briseno-Roa
- HiFiBiO Therapeutics SAS, Paris, France.,Medetia Pharma, Institut Imagine, Paris, France
| | - Pablo Canales-Herrerias
- Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France.,École Doctorale Frontières du Vivant (FdV), Centre de Recherches Interdisciplinaires, Paris, France.,Laboratoire Colloïdes et Matériaux Divisés (LCMD), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France
| | | | | | | | | | | | - Bin Jia
- Pfizer, Cambridge, MA, USA.,Abbvie Bioresearch Center, Worcester, MA, USA
| | - Bruno Iannascoli
- Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France
| | - Odile Richard-Le Goff
- Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France
| | | | | | | | | | - Kevin Grosselin
- HiFiBiO Therapeutics SAS, Paris, France.,Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France
| | - Baptiste Saudemont
- Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France.,Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France
| | - Antoine Sautel-Caillé
- Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France
| | - Alexei Godina
- Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France
| | | | - Klaus Eyer
- Laboratoire Colloïdes et Matériaux Divisés (LCMD), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.,Laboratory for Functional Immune Repertoire Analysis, Institute of Pharmaceutical Sciences, D-CHAB, ETH Zürich, Zurich, Switzerland
| | - Gaël A Millot
- Institut Pasteur, Hub Bioinformatique et Biostatistique, C3BI, USR 3756 IP CNRS, Paris, France
| | - Jean Baudry
- Laboratoire Colloïdes et Matériaux Divisés (LCMD), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France
| | - Patrick England
- Plateforme de Biophysique Moléculaire, Institut Pasteur, CNRS UMR3528, Paris, France.,Centre d'Innovation et de Technologie, Plateforme de Biophysique des Macromolecules et de leurs Interactions, Institut Pasteur, Paris, France
| | - Clément Nizak
- Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France
| | - Allan Jensen
- HiFiBiO Therapeutics SAS, Paris, France.,Lundbeck A/S, Valby, Denmark
| | - Andrew D Griffiths
- Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.
| | - Pierre Bruhns
- Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France.
| | - Colin Brenan
- HiFiBiO Therapeutics SAS, Paris, France. .,HiFiBiO Therapeutics Inc., Cambridge, MA, USA. .,1CellBiO Inc., Watertown, MA, USA.
| |
Collapse
|
12
|
Gambaro K, Marques M, McNamara S, du Tertre MC, Hoffert C, Srivastava A, Samson B, Lesperance B, Ko Y, Dalfen R, St-Hilaire E, Sideris L, Couture F, Burkes R, Harb M, Camlioglu E, Gologan A, Pelsser V, Tejpar S, Kavan P, Kleinman C, Batist G. Copy number variation in longitudinal liver metastases biopsies in colorectal cancer identifies biomarker candidates of resistance to standard chemotherapy. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz154.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
13
|
Nelson M, Ratjen A, Bautista G, McNamara S, Nay L, Majors C, Vo A, Hayden H, Brittnacher M, LiPuma J, Simon R, Hoffman L. P145 Effect of cycled tobramycin on the sputum microbiome in cystic fibrosis. J Cyst Fibros 2019. [DOI: 10.1016/s1569-1993(19)30439-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
14
|
Wolter D, Onchiri F, Emerson J, Precit M, Lee M, McNamara S, Nay L, Blackledge M, Uluer A, Mann M, Orenstein D, Hoover W, Burns J, Hoffman L. ePS6.01 Prevalence and clinical significance of Staphylococcus aureus smallcolony variants: a prospective longitudinal, multicentre study. J Cyst Fibros 2019. [DOI: 10.1016/s1569-1993(19)30287-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
15
|
Lee D, Amadi A, Sabater J, Ellis J, Johnson H, Kotapati S, McNamara S, Walker A, Cooper M, Patterson K, Roskell N, Meng Y. Can We Accurately Predict Cost Effectiveness Without Access to Overall Survival Data? The Case Study of Nivolumab in Combination with Ipilimumab for the Treatment of Patients with Advanced Melanoma in England. Pharmacoecon Open 2019; 3:43-54. [PMID: 29790020 PMCID: PMC6393277 DOI: 10.1007/s41669-018-0080-5] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/17/2023]
Abstract
BACKGROUND Nivolumab with ipilimumab (the Regimen) is the first immuno-oncology combination treatment to demonstrate long-term clinical benefit for advanced melanoma patients. We evaluated the cost effectiveness of the Regimen in this population, with and without the availability of overall survival (OS) data. METHODS A partitioned survival model and a Markov state-transition model were developed to estimate the lifetime costs and benefits of the Regimen versus ipilimumab. These models were built with and without the availability of OS data, as only progression-free survival data were available from the head-to-head, phase III trial against ipilimumab at the time of the National Institute for Health and Care Excellence (NICE) submission. Patient utilities and resource use data were sourced from trial data or the literature. RESULTS Incremental cost-effectiveness ratios (ICERs) and absolute costs were similar between the models with and without OS data, but the model with OS data generated more than 1 additional quality-adjusted life-year (QALY) across both treatment arms. In both models, based on list prices, the Regimen was the most cost-effective treatment. CONCLUSIONS The analyses show that the Regimen is a cost-effective treatment for advanced melanoma patients in England, and methods to overcome the lack of OS can give reasonable estimates of QALYs gained and ICERs.
Collapse
Affiliation(s)
- D Lee
- BresMed Health Solutions, Sheffield, UK.
| | - A Amadi
- Bristol-Myers Squibb Pharmaceuticals, Uxbridge, UK
| | - J Sabater
- Bristol-Myers Squibb, Princeton, NJ, USA
| | - J Ellis
- Bristol-Myers Squibb Pharmaceuticals, Uxbridge, UK
| | - H Johnson
- Helen Johnson Consulting Ltd, Welwyn Garden City, UK
| | - S Kotapati
- Bristol-Myers Squibb, Princeton, NJ, USA
| | - S McNamara
- School of Health and Related Research, University of Sheffield, Sheffield, UK
| | | | - M Cooper
- BresMed Health Solutions, Sheffield, UK
| | | | - N Roskell
- BresMed Health Solutions, Sheffield, UK
| | - Y Meng
- BresMed Health Solutions, Sheffield, UK
| |
Collapse
|
16
|
Lee D, Amadi A, Sabater J, Ellis J, Johnson H, Kotapati S, McNamara S, Walker A, Cooper M, Patterson K, Roskell N, Meng Y. Correction to: Can We Accurately Predict Cost Effectiveness Without Access to Overall Survival Data? The Case Study of Nivolumab in Combination with Ipilimumab for the Treatment of Patients with Advanced Melanoma in England. Pharmacoecon Open 2019; 3:127. [PMID: 30206825 PMCID: PMC6393273 DOI: 10.1007/s41669-018-0096-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
The second Key Point for Decision Makers, which reads.
Collapse
Affiliation(s)
- D Lee
- BresMed Health Solutions, Sheffield, UK.
| | - A Amadi
- Bristol-Myers Squibb Pharmaceuticals, Uxbridge, UK
| | - J Sabater
- Bristol-Myers Squibb, Princeton, NJ, USA
| | - J Ellis
- Bristol-Myers Squibb Pharmaceuticals, Uxbridge, UK
| | - H Johnson
- Helen Johnson Consulting Ltd, Welwyn Garden City, UK
| | - S Kotapati
- Bristol-Myers Squibb, Princeton, NJ, USA
| | - S McNamara
- School of Health and Related Research, University of Sheffield, Sheffield, UK
| | | | - M Cooper
- BresMed Health Solutions, Sheffield, UK
| | | | - N Roskell
- BresMed Health Solutions, Sheffield, UK
| | - Y Meng
- BresMed Health Solutions, Sheffield, UK
| |
Collapse
|
17
|
Isaacowitz D, Newman A, Carr D, Pruchno R, Sands L, McNamara S. HOW TO PUBLISH: ROUND TABLE DISCUSSIONS WITH JOURNAL EDITORS. Innov Aging 2018. [DOI: 10.1093/geroni/igy023.842] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- D Isaacowitz
- Northeastern University, Boston, Massachusetts, United States
| | - A Newman
- University of Pittsburgh, Pittsburgh, PA, USA; Editor, The Journals of Gerontology: Medical Sciences, The Gerontological Society of America, Washington, DC, USA
| | - D Carr
- Boston University, Boston, MA, USA
| | - R Pruchno
- Rowan University, Stratford, NJ, USA
| | - L Sands
- Virginia Tech, Blacksburg, VA, USA
| | - S McNamara
- Oxford University Press, New York, NY, USA
| |
Collapse
|
18
|
McNamara S. HOW TO MAXIMIZE THE REACH OF YOUR PUBLISHED WORK. Innov Aging 2018. [DOI: 10.1093/geroni/igy023.841] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- S McNamara
- Oxford University Press, New York, New York, United States
| |
Collapse
|
19
|
Yaung S, Xi L, Woestmann C, McNamara S, Hinzmann B, Froehler S, Tikoo N, Ju C, Balasubramanyam A, Adams HP, Thomas M, Lasitschka F, Meister M, Schneider M, Herth F, Muley T, Wehnl B, Palma J, Ma X. Ecological diversity indices as measurements of tumor heterogeneity correlates with clinical outcomes in late stage small cell lung cancer (SCLC). Ann Oncol 2018. [DOI: 10.1093/annonc/mdy269.168] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
20
|
Couetoux Du Tertre M, Marques M, Izzi L, Tremblay L, Bouchard N, Diaconescu R, Blais N, Hoffert C, Srivastava A, McNamara S, Batist G, Cohen V, Agulnik J. P2.01-23 Baseline Plasma Biomarkers Predict Long-Term Responses to ALK-TKIs in ALK+ Advanced Non-Small Cell Lung Cancer (NSCLC). J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.1077] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
21
|
Marques M, Gambaro K, du Tertre MC, Witcher M, Samson B, Lesperance B, Ko Y, Dalfen R, St-Hilaire E, Sideris L, Couture F, Tejpar S, Burkes R, Harb M, Alcindor T, Camlioglu E, Gologan A, Pelsser V, McNamara S, Kavan P, Kleinman C, Batist G. Characterizations of DNA copy number variations and spatio-temporal intra tumor heterogeneity in liver metastasis from colorectal cancer patients. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy150.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
22
|
Moore WR, Burr LE, McNamara S, Clark PR, Peine NA, Finstuen T, Herold DL, Brown V, Warner C, Trapp GC, Lipford MC, Olson EJ, Auger RR, St. Louis EK, Junna MR. 1080 The Collaborative Care Visit Model: A New Way to Provide Ongoing Care Targeted to Long-Term Stable Positive Airway Pressure Users. Sleep 2018. [DOI: 10.1093/sleep/zsy061.1079] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
23
|
Edwards TC, Emerson J, Genatossio A, McNamara S, Goss C, Patrick DL, Onchiri F, Rosenfeld M. Initial development and pilot testing of observer-reported outcomes (ObsROs) for children with cystic fibrosis ages 0-11years. J Cyst Fibros 2018; 17:680-686. [PMID: 29358075 DOI: 10.1016/j.jcf.2017.12.008] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2017] [Revised: 12/12/2017] [Accepted: 12/20/2017] [Indexed: 11/15/2022]
Abstract
PURPOSE Patient-reported outcomes are important clinical trial endpoints. Young children may not be able to reliably report on how they feel or function, so observer-reported outcomes (ObsROs) may be more appropriate for them. The purpose of this study was to develop and pilot field test electronic parent-reported observational instruments for children with cystic fibrosis (CF) 0-6 and 7-11years of age. METHODS We performed concept elicitation interviews with parents of children with CF ≤11years of age to elicit the respiratory signs they could observe at baseline and during an acute respiratory illness. The resulting instruments were refined based on interviews with parents and clinicians. We conducted a pilot field test to evaluate test-retest reliability and the ability of items to distinguish well and sick periods. RESULTS The instruments consist of 17 items assessing respiratory signs and observable CF-related impacts. Test-retest reliability was acceptable for both age groups but discrimination was low for ages 7-11, likely reflecting less direct observation of older children by their parents. CONCLUSIONS An ObsRO for children with CF ages 0-6 appears promising, while self-report may be more appropriate for children >6years of age. Next steps for the 0-6year old instrument will be utilizing it as an exploratory endpoint in clinical trials to enable item reduction, scale development, and further reliability and validity testing. Ultimately, this ObsRO could be a promising endpoint for early intervention trials in young children with CF.
Collapse
Affiliation(s)
- T C Edwards
- Department of Health Services, University of Washington, 1208 NE 43rd St. - Campus Box 359455, Seattle, WA 98195-9455, United States.
| | - J Emerson
- Division of Pulmonary Medicine, Seattle Children's Hospital, United States.
| | - A Genatossio
- Division of Pulmonary Medicine, Seattle Children's Hospital, United States.
| | - S McNamara
- Division of Pulmonary Medicine, Seattle Children's Hospital, United States.
| | - C Goss
- Department of Medicine and Pediatrics, University of Washington, Division of Pulmonary and Critical Care Medicine, United States.
| | - D L Patrick
- Department of Health Services, University of Washington, 1208 NE 43rd St. - Campus Box 359455, Seattle, WA 98195-9455, United States.
| | - F Onchiri
- Center for Biomedical Statistics, Seattle Children's Research Institute, Seattle, WA, United States; Center for Clinical and Translational Research, Seattle Children's Research Institute, Seattle, WA, United States.
| | - M Rosenfeld
- Department of Pediatrics, University of Washington, Division of Pulmonary Medicine, Seattle Children's Hospital, United States.
| |
Collapse
|
24
|
Dillon SR, Adams D, Goudy L, Bittner M, McNamara S. Evaluating Exercise as Evidence-Based Practice for Individuals with Autism Spectrum Disorder. Front Public Health 2017; 4:290. [PMID: 28224122 PMCID: PMC5293813 DOI: 10.3389/fpubh.2016.00290] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2016] [Accepted: 12/20/2016] [Indexed: 12/02/2022] Open
Abstract
Background The purpose of this study was to conduct a systematic review of the literature to evaluate empirical support for the use of exercise as an evidence-based practice (EBP) for individuals with autism spectrum disorder (ASD), aged 1–21 years, using the Adapted Physical Activity Taxonomy (APAT) (1). Method A systematic review of research, published within the past 10 years and accessible in SPORTDiscus, ProQuest Nursing, Science Direct, ERIC, Ovid MEDLINE, and PsychINFO databases, was conducted following seven inclusion criteria. An initial 169 articles were identified of which 23 articles were found that met the inclusion criteria including implementation of an exercise intervention for participants diagnosed with ASD and utilization of an experimental/quasi experimental, correlational, single–subject, or qualitative research design. These 23 articles were evaluated using the APAT to determine the quality of the research and the strength of the recommendation in establishing exercise as an EBP. Results Of the 23 articles evaluated, 17 employed an experimental/quasi experimental design, 1 article employed a correlational design, and 5 articles employed a single-subject design. Only one article (2) was found to meet the minimum overall quality indicator of moderate (i.e., Level 2) when evaluated on the APAT. In total, 13 of the 23 articles (57%) had method sections evaluated as weak, and 17 of the 23 articles (74%) had results sections evaluated as weak. Conclusion From the findings of this systematic review, and in accordance with the Every Student Succeeds Act of 2015 (3) definition of an EBP, it appears that exercise can be considered an EBP for school-aged children with ASD. However, this recommendation is based solely on moderate evidence from one well-designed and well-implemented experimental study; therefore, generalization is still pending further similar findings. Recommendations for future research are offered.
Collapse
Affiliation(s)
| | - David Adams
- Texas Woman's University, Kinesiology , Denton, TX , USA
| | - Leah Goudy
- Texas Woman's University, Kinesiology , Denton, TX , USA
| | | | - Scott McNamara
- Texas Woman's University, Kinesiology , Denton, TX , USA
| |
Collapse
|
25
|
Rooney A, Zienius K, Heimans L, Woltz S, McNamara S, Grant R. PO67LEVETIRACETAM MAY BE INDEPENDENTLY ASSOCIATED WITH HIGHER FATIGUE IN ADULT GLIOMA OUTPATIENTS. Neuro Oncol 2015. [DOI: 10.1093/neuonc/nov284.60] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
26
|
McNamara S, Stokes S, Kilduff R, Shine A. Pregabalin Abuse amongst Opioid Substitution Treatment Patients. Ir Med J 2015; 108:309-310. [PMID: 26817289] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
Pregabalin (Lyrica®) is used in treating epilepsy, nerve pain and anxiety. Pregabalin was initially thought to have a low misuse potential however there are emerging reports of Pregabalin being abused. A study was commenced at the National Drug Treatment Centre's (NDTC) Drug Analysis Laboratory to determine the level of usage of Pregabalin within the addiction services population in Ireland. A total of 498 urine samples representing samples from 440 individual opioid substitution patients, initially screened by immunoassay for drugs of abuse, were subjected to further analysis for Pregabalin by Liquid Chromatography/Mass Spectrometry (LC/MS). Of 440 patients tested, 39 tested positive for Pregabalin (9.2%). Only 10 patients from this group were prescribed this drug to our knowledge thus giving an estimated rate of misuse of 7.0%. Other drugs detected in the Pregabalin positive patients were Opiates (31.8%), Cocaine (11.4%), Benzodiazepines (79.5%) and Cannabis (77.8%). Our study confirms that Pregabalin abuse is taking place amongst the addiction services population. We believe that misuse of this prescription drug is a serious emerging issue which should be monitored carefully.
Collapse
|
27
|
McNamara L, McNamara S. Testing The Utility Of The Nhs's Systemic Anti-Cancer Therapy Data Set For Multi-Indication Pricing. Value Health 2014; 17:A659. [PMID: 27202396 DOI: 10.1016/j.jval.2014.08.2411] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Affiliation(s)
- L McNamara
- Roche Products Ltd., Welwyn Garden City, UK
| | - S McNamara
- Roche Products Ltd., Welwyn Garden City, UK
| |
Collapse
|
28
|
Koekkoek JAF, Dirven L, Reijneveld JC, Pasman HRW, McNamara S, Grisold W, Stockhammer G, Marosi C, Taphoorn MJB, Heimans JJ. O9.08 * END OF LIFE CARE IN HIGH-GRADE GLIOMA PATIENTS IN THREE EUROPEAN COUNTRIES: A COMPARATIVE STUDY. Neuro Oncol 2014. [DOI: 10.1093/neuonc/nou174.79] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
29
|
McNamara S, Day JC, Erridge S, Peoples S, Grant R. P15.03 * CARER PERCEPTIONS OF THE END OF LIFE PHASE IN MALIGNANT GLIOMA IN SOUTH EAST SCOTLAND. Neuro Oncol 2014. [DOI: 10.1093/neuonc/nou174.282] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
30
|
Koekkoek JAF, Dirven L, Sizoo EM, Pasman HRW, Heimans JJ, Postma TJ, Deliens L, Grant R, McNamara S, Stockhammer G, Medicus E, Taphoorn MJB, Reijneveld JC. Symptoms and medication management in the end of life phase of high-grade glioma patients. J Neurooncol 2014; 120:589-95. [DOI: 10.1007/s11060-014-1591-2] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2014] [Accepted: 08/16/2014] [Indexed: 10/24/2022]
|
31
|
Koekkoek JAF, Dirven L, Reijneveld JC, Sizoo EM, Pasman HRW, Postma TJ, Deliens L, Grant R, McNamara S, Grisold W, Medicus E, Stockhammer G, Oberndorfer S, Flechl B, Marosi C, Taphoorn MJB, Heimans JJ. End of life care in high-grade glioma patients in three European countries: a comparative study. J Neurooncol 2014; 120:303-10. [DOI: 10.1007/s11060-014-1548-5] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2014] [Accepted: 07/06/2014] [Indexed: 11/29/2022]
|
32
|
McEwen SCJ, Connolly CG, Kelly AMC, Kelleher I, O’Hanlon E, Clarke M, Blanchard M, McNamara S, Connor D, Sheehan E, Donohoe G, Cannon M, Garavan H. Resting-state connectivity deficits associated with impaired inhibitory control in non-treatment-seeking adolescents with psychotic symptoms. Acta Psychiatr Scand 2014; 129:134-42. [PMID: 23621452 PMCID: PMC3787979 DOI: 10.1111/acps.12141] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 03/27/2013] [Indexed: 12/14/2022]
Abstract
OBJECTIVE Psychotic symptoms are common in the population and index risk for a range of severe psychopathological outcomes. We wished to investigate functional connectivity in a community sample of adolescents who reported psychotic symptoms (the extended psychosis phenotype). METHOD This study investigated intrinsic functional connectivity (iFC) during resting-state functional magnetic resonance imaging (fMRI; rs-fMRI). Following screening in schools, 11 non-treatment seeking, youth with psychotic symptoms (aged 11-13) and 14 community controls participated in the study. Seed regions of interest comprised brain regions previously shown to exhibit aberrant activation during inhibitory control in adolescents with psychotic symptoms. RESULTS Relative to controls, adolescents with psychotic symptoms exhibited reduced iFC between regions supporting inhibitory control. Specifically, they showed weaker iFC between the right inferior frontal gyrus (IFG) and the cingulate, IFG and the striatum, anterior cingulate and claustrum, and precuneus and supramarginal gyrus. Conversely, the psychotic symptoms group exhibited stronger iFC between the superior frontal gyrus and claustrum and IFG and lingual gyrus. CONCLUSION The present findings are the first to reveal aberrant functional connectivity in resting-state networks in a community sample of adolescents with psychotic symptoms and suggest that disruption in integration between distributed neural networks (particularly between prefrontal, cingulate and striatal brain regions) may be a key neurobiological feature of the extended psychosis phenotype.
Collapse
Affiliation(s)
- S. C. Jacobson McEwen
- School of Psychology, Trinity College Dublin, Dublin, Ireland,Department of Psychiatry & Biobehavioral Sciences, University of California, Los Angeles, CA
| | - C. G. Connolly
- School of Psychology, Trinity College Dublin, Dublin, Ireland,Department of Psychiatry, University of California, San Francisco, CA
| | - A. M. C. Kelly
- Phyllis Green and Randolph Cowen Institute for Pediatric Neuroscience, New York University Child Study Center, New York, NY, USA,Department of Psychiatry and Psychology, Royal College of Surgeons in Ireland, Dublin
| | - I. Kelleher
- Department of Psychiatry and Psychology, Royal College of Surgeons in Ireland, Dublin
| | - E. O’Hanlon
- Department of Psychiatry and Psychology, Royal College of Surgeons in Ireland, Dublin
| | - M. Clarke
- Department of Psychiatry and Psychology, Royal College of Surgeons in Ireland, Dublin
| | - M. Blanchard
- Department of Psychiatry and Psychology, Royal College of Surgeons in Ireland, Dublin
| | - S. McNamara
- School of Psychology, Trinity College Dublin, Dublin, Ireland
| | - D. Connor
- School of Psychology, Trinity College Dublin, Dublin, Ireland
| | - E. Sheehan
- School of Psychology, Trinity College Dublin, Dublin, Ireland
| | - G. Donohoe
- Department of Psychiatry & Neuropsychiatric Genetics Research Group, School of Medicine and Trinity College Institute of Neuroscience, Trinity College, Dublin
| | - M. Cannon
- Department of Psychiatry and Psychology, Royal College of Surgeons in Ireland, Dublin,Department of Psychiatry, Beaumont Hospital, Dublin, Ireland
| | - H. Garavan
- School of Psychology, Trinity College Dublin, Dublin, Ireland,Departments of Psychiatry and Psychology, University of Vermont, Burlington, VT, USA
| |
Collapse
|
33
|
Diaz Z, Przybytkowski E, Lan C, McNamara S, Aguilar-Mahecha A, Camlioglu E, Gologan A, Batist G, Basik M. MC13-0077 Array CGH analysis of paired metastatic biopsies obtained pre-treatment and at resistance to FOLFOX-bevacizumab in metastatic CRC patients. Eur J Cancer 2013. [DOI: 10.1016/s0959-8049(13)70183-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
34
|
Acquaye AA, Vera-Bolanos E, Gilbert MR, Armstrong TS, Lin L, Amidei C, Lovely M, Arzbaecher J, Page M, Mogensen K, Lupica K, Maher ME, Armstrong TS, Won M, Wefel JS, Gilbert MR, Pugh S, Wendland MM, Brachman DG, Brown PD, Crocker IR, Robins HI, Lee RJ, Mehta M, Arvold N, Wang Y, Zigler C, Schrag D, Dominici F, Boele F, Douw L, de Groot M, van Thuijl H, Cleijne W, Heimans J, Taphoorn M, Reijneveld J, Klein M, Bunevicius A, Tamasauskas S, Tamasauskas A, Deltuva V, Bunevicius R, Cahill J, Lin L, Armstrong T, Acquaye A, Vera-Bolanos E, Gilbert M, Padhye N, Chan J, Clarke J, Lawton K, Rabbitt J, DeSilva A, Prados M, Rosen M, Cher L, Diamond E, Applebaum A, Corner G, DeRosa A, Breitbart W, DeAngelis L, Hoogendoorn P, Ikuta S, Muragaki Y, Maruyama T, Nitta M, Tamura M, Okamoto S, Iseki H, Okada Y, Lacouture M, Davis ME, Elzinga G, Butowski N, Tran D, Villano J, Wong E, Legge D, Cher L, Legge D, Cher L, Mills K, Lin L, Acquaye A, Vera-Bolanos E, Gilbert M, Armstrong T, Lovely M, Sullivan D, Mueller S, Fullerton H, Stratton K, Leisenring W, Armstrong G, Weathers R, Stovall M, Goldsby R, Sklar C, Robison L, Krull K, Pace A, Villani V, Focarelli S, Benincasa D, Benincasa A, Carapella CM, Pompili A, Peiffer AM, Burke A, Leyer CM, Shing E, Kearns WT, Hinson WH, Case D, Rapp SR, Shaw EG, Chan MD, Porensky E, Cavaliere R, Newton H, Shilds A, Burgess S, Ravelo A, Taylor F, Mazar I, Abrey L, Rooney A, Graham C, McKenzie H, Fraser M, MacKinnon M, McNamara S, Rampling R, Carson A, Grant R, Rooney A, Heimans L, Woltz S, Kerrigan S, McNamara S, Grant R, Seibl-Leven M, Wittenstein K, Rohn G, Goldbrunner R, Timmer M, Kennedy J, Sherman W, Sen-Gupta I, Garic I, Macken M, Gerard E, Raizer J, Schuele S, Grontoft M, Stragliotto G, Taphoorn MJ, Henriksson R, Bottomley A, Cloughesy T, Wick W, Mason W, Saran F, Nishikawa R, Ravelo A, Hilton M, Chinot OL, Trad W, Simpson T, Wright K, Tran T, Choong C, Barton M, Hovey E, Robinson K, Koh ES, Vera-Bolanos E, Acquaye AA, Brown PD, Chung C, Gilbert MR, Vardy J, Armstrong TS, Walbert T, Mendoza T, Vera-Bolanos E, Gilbert M, Acquaye A, Armstrong T, Walbert T, Glantz M, Schultz L, Puduvalli VK, Oudenhoven M, Farin C, Hoffman R, Armstrong T, Ewend M, Wu J. SYMPTOM MANAGEMENT/QUALITY OF LIFE. Neuro Oncol 2013; 15:iii226-iii234. [PMCID: PMC3823907 DOI: 10.1093/neuonc/not192] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2024] Open
|
35
|
Wang T, Fontenla S, McCann P, Young R, McNamara S, Mechalakos J, Lee N. Correlation of Planned Dose to Area Postrema and Dorsal Vagal Complex With Clinical Symptoms of Nausea and Vomiting in a Series of Oropharyngeal Cancer (OPC) Patients Treated With Radiation Alone Using IMRT. Int J Radiat Oncol Biol Phys 2012. [DOI: 10.1016/j.ijrobp.2012.07.1237] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
36
|
Pefani E, Panoskaltsis N, Mantalaris A, Georgiadis MC, Pistikopoulos EN, Aguilar-Mahecha A, Lafleur J, Seguin C, Rosenbloom M, Przybytkowski E, Pelmus M, Diaz Z, Batist G, Basik M, Tavernier J, Brunet L, Bazot J, Chemelle M, Dalban C, Guiu S, di Martino C, Lehtio J, Branca M, Johansson H, Orre M, Granholm V, Forshed J, Perez-Bercoff M, Kall L, Nielsen KV, Andresen L, Muller S, Matthiesen S, Schonau A, Oktriani R, Wahyono A, Haryono S, Utomo A, Aryandono T, Diaz Z, Gagnon-Kugler T, Rousseau C, Aguilar-Mahecha A, Alcindor T, Aloyz R, Assouline S, Basik M, Bachvarov D, Belanger L, Camlioglu E, Cartillone M, Chabot B, Christodoulopoulos R, Courtemanche C, Constantin A, Benlimame N, Dao I, Dalfen R, Gosselin L, Habbab F, Hains M, Haliotis T, Nielsen TH, Joncas M, Kavan P, Klink R, Langlaben A, Lebel M, Lesperance B, Mann K, Masson J, Metrakos P, McNamara S, Miller WH, Orain M, Panasci L, Paquet E, Phillie M, Qureshi S, Rodrigue D, Salman A, Spatz A, Tetu B, Tosikyan A, Tsatoumas M, Vuong T, Batist G, Ruijtenbeek R, Houtman R, de Wijn R, Boender P, Hilhorst R, Cohen Y, Onn A, Lax A, Yosepovich A, Litz S, Kalish S, Felemovicius R, Hout-Silony G, Gutman M, Shabtai M, Rosin D, Valeanu A, Winkler E, Sklair-Levy M, Kaufman B, Barshack I, Canu V, Sacconi A, Biagioni F, Mori F, di Benedetto A, Lorenzon L, di Agostino S, Cambria A, Germoni S, Grasso G, Blandino R, Panebianco V, Ziparo V, Federici O, Muti P, Strano S, Carboni F, Mottolese M, Diodoro MG, Pescarmona E, Garofalo A, Blandino G, Ho T, Feng L, Lintula S, Orpana KA, Stenman J, El Messaoudi S, Mouliere F, del Rio M, Guedj AS, Gongora C, Molina FM, Lamy PJ, Lopez-Crapez E, Rolet F, Mathonnet M, Ychou M, Pezet D, Thierry AR, Manuarii M, Tredan O, Bachelot T, Clapisson G, Courtier A, Parmentier G, Rabeony T, Grives A, Perez S, Mouret JF, Perol D, Chabaud S, Ray-Coquard I, Labidi-Galy I, Heudel P, Pierga JY, Caux C, Blay JY, Pasqual N, Menetrier-Caux C. Technology & tools development. Ann Oncol 2012. [DOI: 10.1093/annonc/mds163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
37
|
Diaz Z, Gagnon-Kugler T, Rousseau C, Aguilar-Mahecha A, Alcindor T, Aloyz R, Assouline S, Basik M, Bachvarov D, Bélanger L, Camlioglu E, Cartillone M, Chabot B, Christodoulopoulos R, Courtemanche C, Constantin A, Benlimame N, Dao I, Dalfen R, Gosselin L, Habbab F, Hains M, Haliotis T, Nielsen T, Joncas M, Kavan P, Klink R, Langlaben A, Lebel M, Lespérance B, Mann K, Masson J, Metrakos P, McNamara S, Miller W, Orain M, Panasci L, Paquet E, Phillie M, Qureshi S, Rodrigue D, Salman A, Spatz A, Têtu B, Tosikyan A, Tsatoumas M, Vuong T, Batist G. P3.07 Building the Organization Framework for Biopsy-Driven Translational Research: The Quebec Clinical Research Organization in Cancer (Q-Croc) Experience. Ann Oncol 2012. [DOI: 10.1016/s0923-7534(20)31360-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
38
|
Ammoun S, Zhou L, Barczyk M, Hilton D, Hafizi S, Hanemann C, Lehnus KS, Donovan LK, Pilkington GJ, An Q, Anderson IA, Thomson S, Bailey M, Lekka E, Law J, Davis C, Banfill K, Loughrey C, Hatfield P, Bax D, Elliott R, Bishop R, Taylor K, Marshall L, Gaspar N, Viana-Pereira M, Reis R, Renshaw J, Ashworth A, Lord C, Jones C, Bellamy C, Shaw L, Alder J, Shorrocks A, Lea R, Birks S, Burnet M, Pilkington G, Bruch JD, Ho J, Watts C, Price SJ, Camp S, Apostolopoulos V, Mehta A, Roncaroli F, Nandi D, Clark B, Mackinnon M, MacLeod N, Stewart W, Chalmers A, Cole A, Hanna G, Bailie K, Conkey D, Harney J, Darlow C, Chapman S, Mohsen L, Price S, Donovan L, Birks S, Pilkington G, Dyer H, Lord H, Fletcher K, das Nair R, MacNiven J, Basu S, Byrne P, Glancz L, Critchley G, Grech-Sollars M, Saunders D, Phipps K, Clayden J, Clark C, Greco A, Acquati S, Marino S, Hammouche S, Wilkins SP, Smith T, Brodbelt A, Hammouche S, Clark S, Wong AHL, Eldridge P, Farah JO, Ho J, Bruch J, Watts C, Price S, Lamb G, Smith S, James A, Glegg M, Jeffcote T, Boulos S, Robbins P, Knuckey N, Banigo A, Brodbelt AR, Jenkinson MD, Jeyapalan JN, Mumin MA, Forshew T, Lawson AR, Tatevossian RG, Jacques TS, Sheer D, Kilday J, Wright K, Leavy S, Lowe J, Schwalbe E, Clifford S, Gilbertson R, Coyle B, Grundy R, Kinsella P, Clynes M, Amberger-Murphy V, Barron N, Lambert SR, Jones D, Pearson D, Ichimura I, Collins V, Steele L, Sinha P, Chumas P, Tyler J, Ogawa D, Chiocca E, DeLay M, Bronisz A, Nowicki M, Godlewski J, Lawler S, Lee MK, Javadpour M, Jenkinson MD, Lekka E, Abel P, Dawson T, Lea B, Davis C, Lim CSK, Grundy PL, Pendleton M, Lord H, Mackinnon M, Williamson A, James A, Stewart W, Clark B, Chalmers A, Merve A, Zhang X, Marino S, Miller S, Rogers HA, Lyon P, Rand V, Adamowicz-Brice M, Clifford SC, Hayden JT, Dyer S, Pfister S, Korshunov A, Brundler MA, Lowe J, Coyle B, Grundy RG, Nankivell M, Mulvenna P, Barton R, Wilson P, Faivre-Finn C, Pugh C, Langley R, Ngoga D, Tennant D, Williams A, Moss P, Cruickshank G, Owusu-Agyemang K, Bell S, Stewart W, St.George J, Piccirillo SG, Watts C, Qadri S, Pirola E, Jenkinson M, Brodbelt A, Rahman R, Rahman C, Smith S, MacArthur D, Rose F, Shakesheff K, Grundy R, Carroll C, Watson P, Hawkins M, Spoudeas H, Walker D, Holland T, Ring H, Rooney A, McNamara S, Mackinnon M, Fraser M, Rampling R, Carson A, Grant R, Royds J, Al Nadaf S, Ahn A, Chen YJ, Wiles A, Jellinek D, Braithwaite A, Baguley B, MacFarlane M, Hung N, Slatter T, Rusbridge S, Walmsley N, Griffiths S, Wilford P, Rees J, Ryan D, Watts C, Liu P, Galavotti S, Shaked-Rabi M, Tulchinsky E, Brandner S, Jones C, Salomoni P, Schulte A, Gunther HS, Zapf S, Riethdorf S, Westphal M, Lamszus K, Selvanathan SK, Hammouche S, Salminen HJ, Jenkinson MD, Setua S, Watts C, Welland ME, Shevtsov M, Khachatryan W, Kim A, Samochernych K, Pozdnyakov A, Guzhova IV, Romanova IV, Margulis B, Smith S, Rahman R, Rahman C, Barrow J, Macarthur D, Rose F, Grundy R, Smith S, Long A, Barrow J, Macarthur D, Coyle B, Grundy R, Maherally Z, Smith JR, Dickson L, Pilkington GJ, Prabhu S, Harris F, Lea R, Snape TJ, Sussman M, Wilne S, Whitehouse W, Chow G, Liu JF, Walker D, Snape T, Karakoula A, Rowther F, Warr T, Williamson A, Mackinnon M, Zisakis A, Varsos V, Panteli A, Karypidou O, Zampethanis A, Fotovati A, Abu-Ali S, Wang PS, Deleyrolle L, Lee C, Triscott J, Chen JY, Franciosi S, Nakamura Y, Sugita Y, Uchiumi T, Kuwano M, Leavitt BR, Singh SK, Jury A, Jones C, Wakimoto H, Reynolds BA, Pallen CJ, Dunn SE, Shepherd S, Scott S, Bowyer D, Wallace L, Hacking B, Mohsen L, Jena R, Gillard J, Price S, Lee C, Fotovati A, Verraeult M, Wakimoto H, Reynolds B, Dunham C, Bally M, Hukin J, Singhal S, Singh S, Dunn S. Abstracts from the 2011 BNOS Conference, June 29 - July 1, 2011, Homerton College, Cambridge. Neuro Oncol 2011. [DOI: 10.1093/neuonc/nor144] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
39
|
Erridge SC, Hart MG, Kerr GR, Smith C, McNamara S, Grant R, Gregor A, Whittle IR. Trends in classification, referral and treatment and the effect on outcome of patients with glioma: a 20 year cohort. J Neurooncol 2011; 104:789-800. [PMID: 21384218 DOI: 10.1007/s11060-011-0546-0] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2010] [Accepted: 02/18/2011] [Indexed: 10/18/2022]
Abstract
This retrospective audit was conducted to examine the changes in patient characteristics, referral, treatment and outcome over a 20-year period in a large regional neuro-oncology centre, focusing on the impact of the changes in pathological classification of gliomas. Using the Edinburgh Cancer Centre (ECC) database all cases of glioma were identified and patient, tumour and treatment characteristics noted. Survival was calculated from date of surgery or, if no operation was performed, the date of referral. Comparison was made between four periods 1988-1992 (c1), 1993-1997(c2), 1998-2002(c3) and 2003-2007 (c4). During the 20 years, 1175 patients with a glioma were referred to ECC. The median age increased from 53 years to 57 years (p < 0.001) but the proportion without pathology remained unchanged (10%). The distribution of pathological grades changed over time Grade I-II: 24, 6, 6, and 6%, Grade III: 42, 27, 17, and 13% and Grade IV: 24, 61, 68, and 68% in c1, c2, c3 and c4, respectively (p < 0.001). Immediate RT was given to 68% (c1), 70% (c2), 78% (c3) and 79% (c4). Median interval from resection to RT reduced from 43 days (c1) to 36 days (c4) (p < 0.001). 5-year overall survival for patients with Grade III lesions increased: 21% (c1), 35% (c2), 37% (c3), 33% (c4) as did 1-year overall survival for Grade IV lesions: 18% (c1), 26% (c2), 29% (c3), 27% (c4)). This improvement probably reflects the change in pathological classification rather than a change in management. Proportional hazards analysis of grade IV 1993-2007 only (to reduce pathological variation) showed that younger age, frontal lesions, excision, higher RT dose had reduced hazard of death. Interval from surgery to RT had no impact on survival in this series.
Collapse
Affiliation(s)
- S C Erridge
- Edinburgh Centre for Neuro-Oncology, University of Edinburgh, Western General Hospital, Edinburgh, EH4 1EU, UK.
| | | | | | | | | | | | | | | |
Collapse
|
40
|
McNamara S, Nuijten M, Summerhayes M, Ray J, Walzer S. 24 A cost-effectiveness analysis on the use of erlotinib (Tarceva) in the maintenance treatment of locally advanced or metastatic NSCLC patients with stable disease (SD) as best response to induction. Lung Cancer 2011. [DOI: 10.1016/s0169-5002(11)70024-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
41
|
McNamara S, Stokes S, Coleman N. Head shop compound abuse amongst attendees of the Drug Treatment Centre Board. Ir Med J 2010; 103:134-137. [PMID: 20666082] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/29/2023]
Abstract
The use of "Head Shop" compounds has received much media attention lately. There is very little research in the current literature with regard to the extent of the usage of these substances amongst the drug using population in Ireland. We conducted a study to examine the extent of the usage of Mephedrone, Methylone and BZP amongst attendees of Methadone maintenance programs at the DTCB. Two hundred and nine samples in total were tested. The results showed significant usage of these compounds amongst this cohort of drug users, with 29 (13.9%) of samples tested being positive for Mephedrone, 7 (3.3%) positive for Methylone and 1 (0.5%) positive for BZP.
Collapse
Affiliation(s)
- S McNamara
- The Drug Treatment Centre Board, 30-31 Pearse St, Dublin 2
| | | | | |
Collapse
|
42
|
Jacobson S, Kelleher I, Harley M, Connor D, Clarke M, Blanchard M, Connolly C, O'Hanlon E, McNamara S, Donohoe G, Cannon M, Garavan H. An MRI Examination of Cognitive Control and Brain Volumetrics in Schizophrenia Patients and a Community Based Sample of Adolescents with Psychotic Symptoms. Neuroimage 2009. [DOI: 10.1016/s1053-8119(09)71657-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
43
|
McNamara S. 1-benzylpiperazine (BZP) abuse amongst attendees of the Drug Treatment Centre Board. Ir Med J 2009; 102:191. [PMID: 19722361] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
|
44
|
McNamara S, Murphy J, O'Mara F, Rath M, Mee J. Effect of milking frequency in early lactation on energy metabolism, milk production and reproductive performance of dairy cows. Livest Sci 2008. [DOI: 10.1016/j.livsci.2007.11.013] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
45
|
Osanloo F, Kolahchi MR, McNamara S, Herrmann HJ. Sediment transport in the saltation regime. Phys Rev E Stat Nonlin Soft Matter Phys 2008; 78:011301. [PMID: 18763942 DOI: 10.1103/physreve.78.011301] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/21/2007] [Revised: 04/22/2008] [Indexed: 05/26/2023]
Abstract
We present a study of sediment transport in the creeping and saltation regimes. In our model, a bed of particles is simulated with the conventional event-driven method. The particles are considered as hard disks in a two-dimensional domain with periodic boundary conditions in the horizontal direction. The flow of the fluid over this bed of particles is modeled by imposing a force on each particle that depends on the velocity of the fluid at its height above the bed. We consider two velocity profiles for the fluid, parabolic and logarithmic. The first one models laminar flow and the second corresponds to turbulent flow. For each case we investigate the behavior of the saturated flux. We find that for the logarithmic profile, the saturated flux shows a quadratic increase with the strength of the flow, and for parabolic profile, a cubic increase. The velocity distribution functions are used to interpret the results.
Collapse
Affiliation(s)
- F Osanloo
- Institute for Advanced Studies in Basic Sciences, PO Box 45195-1159, Zanjan, Iran
| | | | | | | |
Collapse
|
46
|
McNamara S, García-Rojo R, Herrmann HJ. Microscopic origin of granular ratcheting. Phys Rev E Stat Nonlin Soft Matter Phys 2008; 77:031304. [PMID: 18517367 DOI: 10.1103/physreve.77.031304] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/09/2007] [Indexed: 05/26/2023]
Abstract
Numerical simulations of assemblies of grains under cyclic loading exhibit "granular ratcheting:" a small net deformation occurs with each cycle, leading to a linear accumulation of deformation with cycle number. We show that this is due to a curious property of the most frequently used models of the particle-particle interaction: namely, that the potential energy stored in contacts is path dependent. There exist closed paths that change the stored energy, even if the particles remain in contact and do not slide. An alternative method for calculating the tangential force removes granular ratcheting.
Collapse
Affiliation(s)
- S McNamara
- Institut für Computerphysik, Universität Stuttgart, D-70569 Stuttgart, Germany
| | | | | |
Collapse
|
47
|
Patton J, Kenny DA, McNamara S, Mee JF, O'Mara FP, Diskin MG, Murphy JJ. Relationships among milk production, energy balance, plasma analytes, and reproduction in Holstein-Friesian cows. J Dairy Sci 2007; 90:649-58. [PMID: 17235140 DOI: 10.3168/jds.s0022-0302(07)71547-3] [Citation(s) in RCA: 144] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Associations were examined between components and indicators of early lactation energy balance (EB) and measures of fertility in Holstein cows. Milk production, dry matter intake (DMI), body condition score (BCS), and endocrine and metabolite data from 96 cows were analyzed using multivariate logistic regression and survival analysis. Fertility variables investigated were interval to commencement of luteal activity (C-LA), calving to conception interval (CCI), and conception rate to first service (CON1). Mean daily EB, milk protein content, and DMI during the first 28 d in milk were associated positively with CON1. Cows having poorer BCS (< or =2.25) at first service had a lower CON1. Positive associations were identified among EB, milk protein content, DMI, and the likelihood of a shorter interval to C-LA. Cows having greater DMI and a more positive EB had an increased likelihood of a shorter CCI, whereas a lower nadir BCS was associated with an increased likelihood of a longer CCI. Milk yield was not associated with any of the fertility variables investigated. A greater plasma concentration of insulin-like growth factor I (IGF-I) during the first 2 wk of lactation was associated with a greater CON1 and an increased likelihood of a shorter interval to C-LA. In conclusion, we identified DMI as the principal component of EB influencing subsequent fertility. Furthermore, results indicate that milk protein content and plasma IGF-I concentration in early lactation may be useful indicators of reproductive efficiency.
Collapse
Affiliation(s)
- J Patton
- Teagasc Moorepark Dairy Production Research Centre, Fermoy, Co. Cork, Ireland
| | | | | | | | | | | | | |
Collapse
|
48
|
Erridge S, Kerr G, Hart M, Smith C, McNamara S, Whittle I, Grant R, Gregor A. Audit of Patients with Glioma Referred to Edinburgh Cancer Centre 1988–2002: Pathology, Treatment and Outcome. Clin Oncol (R Coll Radiol) 2007. [DOI: 10.1016/j.clon.2007.01.354] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
49
|
Barbosa-Cesnik C, Krajden M, DeBusscher J, McNamara S, DallaCosta LM, Carvallo N, Foxman B. Staphylococcus Aureus, a Putative Cause of Lactation Mastitis, is Found Very Frequently in Breastmilk of Healthy Women. Am J Epidemiol 2006. [DOI: 10.1093/aje/163.suppl_11.s198-b] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
50
|
Wackenhut M, McNamara S, Herrmann H. Shearing behavior of polydisperse media. Eur Phys J E Soft Matter 2005; 17:237-46. [PMID: 15920666 DOI: 10.1140/epje/i2004-10144-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/29/2004] [Accepted: 04/19/2005] [Indexed: 05/02/2023]
Abstract
We study the shearing of polydisperse and bidisperse media with a size ratio of 10. Simulations are performed with a two-dimensional shear cell using contact dynamics. With a truncated power law for the polydisperse media we find that they show a stronger dilatancy and greater resistance to shearing than bidisperse mixtures. To model additives used to control viscosity we introduce so-called "point-like particles". Even changing the kinematic behavior very little, the point-like particles reduce the force necessary to maintain a fixed shearing velocity.
Collapse
Affiliation(s)
- M Wackenhut
- Institute for Computational Physics, University of Stuttgart, Pfaffenwaldring 27, 70569 Stuttgart, Germany.
| | | | | |
Collapse
|